Latanoprost/Timolol Maleate

拉坦前列素/马来酸噻吗洛尔

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLatanoprost/Timolol Maleate
Drug Alias NameTimolol Maleate/Latanoprost拉坦噻吗Latanoprost and Timolol Maleate马来酸噻吗洛尔/拉坦前列素Xalacom +[7] 
ClassificationSmall molecules
Mechanisms of ActionProstanoid FP receptor agonistsBeta adrenergic receptors antagonists
TargetsProstanoid FP receptorBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritorySweden
Original Approved Date2000/01/01
Country/TerritoryBelgiumUnited StatesSweden +[15] 
CombinationsYes LatanoprostTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Manufacturing Belgium Nv
Inactive CompaniesViatrisLaboratoires Thea SAS
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksN/A